Study for the RevLite Laser System for Facial Solar Lentigines

Inclusion Criteria

• Is a healthy male or female between 18 and 60 years old.
• Is Fitzpatrick Skin types I-III
• Is willing to consent to participate in the study.
• Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits.
• Has clinically determined mild to severe facial mottled pigmentation (solar lentigines) on the face.

Exclusion Criteria

• Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period.
• Is hypersensitive to light exposure OR takes photo sensitized medication.
• Has active or localized systemic infections.
• Has a coagulation disorder or is currently using anti-coagulation medication (including but not limited to the heavy use of aspirin {greater than 81 mg per day}).
• Has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study.
• Is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within 3 months prior to entering this study.
• Has used Accutane within 6 months prior to enrollment.
• Has the need to be exposed to artificial tanning devices or excessive sunlight during the trial.
• Has had prior treatment with parenteral gold therapy (gold sodium thiomalate).
• Has a history of keloids.
• Has evidence of compromised wound healing.
• Has a history of basal cell carcinoma, squamous cell carcinoma or melanoma.
• Has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications or has an autoimmune disorder.